Skip to search formSkip to main contentSkip to account menu

favipiravir

Known as: 6-Fluoro-3-hydroxy-2-pyrazinecarboxamide, T-705, T-705 cpd 
A pyrazinecarboxamide derivative with activity against RNA viruses. Favipiravir is converted to the ribofuranosyltriphosphate derivative by host… 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

AmidesPyrazines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Potential treatment methods targeting 2019-nCoV infection
Review
2020
Review
2020
Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2
Abstract The spread of new coronavirus infection starting December 2019 as novel SARS-CoV-2, identified as the causing agent of… 
2019
2019
T‐705‐modified ssRNA in complex with Lassa virus nucleoprotein exhibits nucleotide splaying and increased water influx into the RNA‐binding pocket
Lassa virus infection is clinically characterized by multiorgan failure in humans. Without an FDA‐approved vaccine, ribavirin is… 
2018
2018
Evaluation of in vitro inhibitory potential of type-I interferons and different antiviral compounds on rabies virus replication.
2018
2018
Identification of tell-tale patterns in the 3′ non-coding region of hantaviruses that distinguish HCPS-causing hantaviruses from HFRS-causing hantaviruses
Hantaviruses are negative-sense, single-stranded RNA viruses with small (S)-, middle (M)-, and large (L)-segments. Each segment… 
2017
2017
Zika Virus Replication Is Substantially Inhibited by Novel Favipiravir and Interferon Alpha Combination Regimens
ABSTRACT Zika virus (ZIKV) is a major public health concern due to its overwhelming spread into the Americas. Currently, there… 
2017
2017
In vitro Susceptibility of Geographically and Temporally Distinct Zika Viruses to Favipiravir and Ribavirin
Background Zika virus, a previously neglected mosquito-borne virus, is prompting worldwide concern because of its connection with… 
2017
2017
Pharmacokinetics of Favipiravir during Continuous Venovenous Haemofiltration in a Critically ill Patient with Influenza
Favipiravir is a novel antiviral drug approved for influenza treatment in Japan. Little is known about favipiravir… 
Review
2017
Review
2017
Experimental Therapies for Ebola Virus Disease: What Have We Learned?
The terrible mortality rate of Ebola virus (EBOV) disease (EVD) is most pronounced in the vulnerable groups of pregnant women and… 
2014
2014
First trials for Ebola treatments announced
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)